MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.
about
Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis.Trps1 is associated with the multidrug resistance of lung cancer cell by regulating MGMT gene expression.
P2860
MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.
@en
type
label
MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.
@en
prefLabel
MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.
@en
P2093
P2860
P1476
MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.
@en
P2093
Junxia Zhang
Weining Wu
Yongping You
Zhumei Shi
P2860
P2888
P356
10.1007/S11060-017-2425-9
P577
2017-04-19T00:00:00Z
P6179
1084923033